If-Converted Method
The if-converted method is the GAAP approach for calculating the dilutive effect of convertible securities — such as convertible bonds, convertible preferred stock, and convertible notes — on diluted EPS, assuming conversion at the beginning of the period and adding back the after-tax interest or preferred dividends that would have been avoided.
The if-converted method applies to instruments that convert into common shares rather than being exercised for cash, distinguishing it from the treasury stock method used for options and warrants. Under ASC 260, the if-converted method assumes that convertible securities were converted into common shares at the start of the reporting period (or on the issuance date if issued during the period), and both the numerator and denominator of the EPS calculation are adjusted accordingly.
For convertible debt: the numerator (net income available to common shareholders) is increased by the after-tax interest expense that would have been avoided had the debt been converted. The denominator (shares outstanding) is increased by the number of shares that would have been issued on conversion. The resulting diluted EPS is compared to basic EPS — if diluted EPS is lower, the instrument is dilutive and is included; if it is higher, it is antidilutive and excluded.
For convertible preferred stock: the numerator is increased by preferred dividends that would not have been paid (or the carrying value difference in the case of accruing instruments), and the denominator is increased by the as-converted common shares.
A critical accounting change affected convertible debt in 2021. ASC 2020-06 eliminated the beneficial conversion feature and cash conversion bifurcation models, simplifying convertible debt accounting and generally requiring use of the if-converted method for all convertible instruments (previously some convertible notes used the treasury stock method). This change increased the diluted share count for companies with convertible debt, sometimes materially.
For analysts valuing companies with significant convertible debt outstanding — common in growth technology and biotech companies — carefully modeling the if-converted dilution is essential for accurate per-share metrics.